Pepto Bismol

Pepto Bismol is an over-the-counter digestive-health brand best known for products containing bismuth subsalicylate. Its medicines are marketed for temporary relief of several common gastrointestinal symptoms, including heartburn, indigestion, nausea, upset stomach, and diarrhea, with the exact claims depending on the product and market. The brand is particularly associated with its distinctive pink liquid, although it is also sold in chewable tablets, caplets, and other solid formats. The product's history is linked to the Norwich Pharmacal Company and to the development of bismuth-based stomach remedies in the United States. The Pepto Bismol name became established as a consumer-facing medicine brand during the twentieth century and was subsequently incorporated into larger consumer-health portfolios. Procter & Gamble acquired the Norwich Eaton Pharmaceuticals business in the early 1980s, bringing Pepto Bismol into its branded health-care operations. The brand later became one of P&G's most recognizable over-the-counter medicines. Pepto Bismol's principal active ingredient, bismuth subsalicylate, combines bismuth and a salicylate component. Product labeling commonly warns consumers about salicylate sensitivity and directs parents and caregivers not to give salicylate-containing products to children or teenagers recovering from certain viral illnesses because of the risk of Reye's syndrome. Labels also warn that temporary darkening of the tongue or stool can occur. These safety and usage restrictions vary by jurisdiction and product, so consumers are expected to follow the local package directions and consult health professionals when symptoms persist or are severe. The brand's positioning combines broad symptom coverage with high visual and verbal recognition. Its pink color, liquid presentation, and memorable advertising have made it an unusually distinctive medicine brand rather than a generic-looking treatment. Marketing has generally emphasized rapid, convenient relief for everyday stomach problems while retaining the authority of an established over-the-counter medicine. In the United States, the product is sold through mass retailers, pharmacies, grocery stores, and e-commerce channels; availability and formulations differ internationally. Pepto Bismol remains an active Procter & Gamble brand in the consumer-health category. It operates alongside the company's other health and personal-care brands, while the medicines themselves remain subject to national labeling, advertising, manufacturing, and safety regulations. Publicly available brand-level information does not establish a standalone corporate headquarters, separate listed entity, or independently reported financial statements for Pepto Bismol.

Pepto Bismol's roots lie in the American pharmaceutical business associated with Norwich Pharmacal. The brand developed from the broader tradition of using bismuth compounds in remedies for gastrointestinal discomfort. During the twentieth century, it became a consumer medicine rather than merely a professional or institutional preparation, with the Pepto Bismol name increasingly linked to a pink liquid containing bismuth subsalicylate. The product's development reflected a familiar pattern in the over-the-counter medicines industry: a specific active ingredient was presented in a standardized, branded format and supported by national advertising and retail distribution. Pepto Bismol became notable not only for the range of stomach symptoms named in its labeling but also for its distinctive appearance. The pink liquid helped distinguish it from competing antacids and antidiarrheal products and became central to the brand's identity. A major corporate turning point came in the early 1980s, when Procter & Gamble acquired Norwich Eaton Pharmaceuticals. The transaction transferred Pepto Bismol into P&G's consumer-health portfolio. Under P&G ownership, the brand benefited from the distribution, marketing, regulatory, and manufacturing capabilities of a large international consumer-goods company. It continued to be sold as a nonprescription gastrointestinal medicine while expanding its presence across retail channels and, in some markets, into additional solid-dose formats. The brand's active ingredient is bismuth subsalicylate. Its labeling has evolved with regulatory requirements and with consumer understanding of appropriate use. Warnings concerning salicylates, children and teenagers recovering from viral illness, allergies, drug interactions, pregnancy or other medical conditions may apply depending on jurisdiction. Temporary blackening of the tongue or stool is a known effect described in consumer information, and persistent or serious symptoms require medical attention rather than continued self-treatment. Pepto Bismol's modern identity is therefore the result of both pharmaceutical continuity and consumer branding. It remains associated with a single recognizable product experience—the pink stomach remedy—while functioning as a line of products sold in several formulations. Procter & Gamble continues to manage it as an active over-the-counter health brand. However, the public record does not provide a complete standalone chronology of every formulation, market launch, ownership change, or advertising campaign, and precise dates for many product-level developments should not be inferred.

1. 1982Acquisition by Procter & Gamble

   Procter & Gamble acquired Norwich Eaton Pharmaceuticals, bringing Pepto Bismol into its consumer-health portfolio.
2. Origins in the Norwich pharmaceutical business

   Pepto Bismol emerged from the Norwich Pharmacal tradition of American gastrointestinal medicines and bismuth-based remedies.
3. Expansion as a branded over-the-counter medicine

   The product developed into a widely distributed consumer brand associated with bismuth subsalicylate and a distinctive pink liquid format.
4. Development of multiple dosage forms

   The brand expanded beyond its signature liquid into chewable tablets, caplets, and other formats whose availability varies by market.

A highly recognizable over-the-counter digestive-relief brand positioned around convenient temporary relief for multiple common stomach symptoms.

• Original liquidLiquid gastrointestinal medicine

  The signature Pepto Bismol presentation is a pink oral liquid containing bismuth subsalicylate. It is marketed for temporary relief of several digestive symptoms, with permitted claims and directions determined by local labeling. The liquid format is strongly associated with the brand's visual identity and remains its best-known offering.

• Chewable tabletsChewable gastrointestinal medicine

  Chewable Pepto Bismol tablets provide the brand's bismuth-subsalicylate treatment in a portable solid form. They are intended for consumers who prefer a format that does not require measuring liquid. Product strength, flavor, directions, and market availability depend on the specific local formulation.

• CapletsSolid-dose gastrointestinal medicine

  Caplets extend the brand into a conventional swallowed-tablet format for digestive relief. Like the liquid and chewable products, they are governed by local medicine labeling and are not interchangeable with every other Pepto Bismol formulation without checking the package directions.

• 1982Transfer into Procter & Gamble's consumer-health portfolioM&A

  Pepto Bismol was part of the Norwich Eaton Pharmaceuticals business acquired by Procter & Gamble.

  What changed. Procter & Gamble acquired the business and continued developing Pepto Bismol as an over-the-counter consumer-health brand.

  Aftermath. The acquisition established Procter & Gamble as the brand's corporate owner and placed it within a larger international distribution and marketing system.